Search
for
Sort by
Research 121–150 of 1000+
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
- Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- An update of polycystic ovary syndrome: causes and therapeutics options
- The association of medications and supplements with human male reproductive health: a systematic review
- Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
- Long-acting microneedle formulations
- Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities
- Cold Atmospheric Plasma for Breast Cancer
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Cancer-Related Alopecia Risk and Treatment
- The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review
- A Review of the Use of Biotin for Hair Loss
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Origanum vulgare L. leaf extract alleviates finasteride-induced oxidative stress in mouse liver and kidney
- FREQUENCY OF DYSLIPIDEMIA IN MALE PATIENTS PRESENTING WITH ANDROGENIC ALOPECIA AT TERTIARY CARE HOSPITAL, KARACHI
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Aging in the sebaceous gland
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Novel Therapeutic Hybrid Systems Using Hydrogels and Nanotechnology: A Focus on Nanoemulgels for the Treatment of Skin Diseases
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer
- Ethnobotanical Survey of Natural Galactagogues Prescribed in Traditional Chinese Medicine Pharmacies in Taiwan